Abstract
A simple and rapid chemiluminescent method for the assay of piroxicam in pure and in pharmaceutical formulations by flow analysis is proposed. The method is based on the reaction of this drug with N-bromosuccinimide (NBS) in alkaline medium in the presence of fluorescein as sensitizer. The emission intensity is greatly enhanced by the presence of cetyltrimethylammonium bromide (CTAB). The optimum chemical conditions for the chemiluminescence emission were investigated. The calibration graph was linear for the concentration range from 2.0 to 12.0 μg mL−1. The detection limit, according to Clayton et al.(C. A. Clayton, J. W. Hines and P. D. Elkins, Anal. Chem., 1987, 59, 2506), was 0.72 μg mL−1. For analysis of 10 solutions of 8.0 μg mL−1 of this anti-inflammatory, if error propagation theory is assumed, the relative error was less than 1.5%. The present chemiluminescence procedure was applied to the determination of piroxicam in Spanish pharmaceutical formulations, with excellent recoveries, as the determination is free from interference from common excipients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
